RealFeedApp Biocapacitance probes are too large for small vessels
The team led by Yves Mermoud created sensors replacing bulky biocapacitance probes. This enables real-time viable cell density monitoring for personalized therapies in small vessels.
- Field
- genetics and genomes
- What they did
- Swiss scientists demonstrated that standard bioprocess monitoring instruments are too large for small laboratories, and traditional cell counting methods do not allow real-time monitoring in small vessels.
- Why it matters
- This is important for personalized medicine, as reducing the size of drug batches requires new solutions for tracking cell viability without using bulky sensors.
#yves mermoud#ost#viable cell density#biocapacitance#process analytical technology
